Sara Monfared, MD
Payments from drug & device makers
Across 77 payments — averaging $153.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Medtronic$1K
- W. L. Gore & Associates, Inc.$1K
- Teleflex LLC$400
- Johnson & Johnson$174
- Baxter Healthcare$161
- plus $714 from 6 others
What the payments were for
- Travel & lodging$4884%
- Food & beverage$4,99542%
- Education$6,28153%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 31 | $7,904 |
| Medtronic | 16 | $1,358 |
| W. L. Gore & Associates, Inc. | 13 | $1,071 |
| Teleflex LLC | 4 | $400 |
| Johnson & Johnson | 3 | $174 |
| Baxter Healthcare | 3 | $161 |
| Davol Inc. | 1 | $150 |
| Activ Surgical, Inc. | 1 | $150 |
| Apollo Endosurgery US Inc | 1 | $148 |
| Polynovo North America LLC | 1 | $138 |
| Novo Nordisk | 2 | $98 |
| Reshape Lifesciences Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$1,173
- Signia$620
- Titan SGS$333
- X-Tack Endoscopic HeliX Tacking System$295
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$249
- Phasix Mesh$150
- ActivSight$150
- OverStitch Endoscopic Suturing System Sx$148
- OverStitch Endoscopic Suturing System$148
- ORBERA Intragastric Balloon System$148
- SEAMGUARD Staple Line Reinforcement$146
- Novosorb BTM$138
- GORE ENFORM Preperitoneal Biomaterial$133
- Echelon Flex$131
- ECHELON ENDOPATH$131
- ETHICON$131
- TISSEEL$130
- SEAMGUARD$109
How this compares
$11,781 in reported general payments places this provider in the 80th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 12 | $1,769 |
| Pantoprazole Sodium | 81 | $1,296 |
Paid to pharmacies, not to this prescriber.
Other surgery in Akron
- Anjay KhandelwalAkron$350K
- John PolouskyAkron$54K
- Jonathan ThompsonWest Chester$2.2M
- Raymond OndersCleveland$1.2M
- Clayton PetroCleveland$1.1M
- Ali AminianCleveland$1.1M
- Michael RosenCleveland$983K
- Michael MearaColumbus$868K
- Neilendu KunduCleveland$808K
- Chase WehrleCleveland$741K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.